SUMMARY Inventors have identified a new problem in the industry, namely that current methods of producing compositions containing trofinetide are difficult to adapt to commercial quantities. To address this problem, we have identified new compositions and production methods in which the compound or salt or stereoisomer or hydrate is produced using silylation technology. The use of this new strategy involves the production of new compositions and substantially larger quantities of trofinetide and results in compositions, kits and products containing trofinetide that are commercially beneficial.
- Forums
- ASX - By Stock
- NEU
- Ann: Comment on research report
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.80%
!
$12.54

Ann: Comment on research report, page-218
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1215 | $12.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.54 | 804 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 12.480 |
1 | 796 | 12.300 |
1 | 400 | 12.240 |
1 | 3000 | 12.230 |
1 | 761 | 12.210 |
Price($) | Vol. | No. |
---|---|---|
12.600 | 1020 | 1 |
12.710 | 628 | 2 |
12.720 | 1982 | 1 |
12.820 | 3050 | 1 |
12.900 | 5012 | 1 |
Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |